Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements5743Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4871Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10635 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 5743

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Ablation Treatment with FARAPULSE™ Pulsed Field Ablation (PFA) System… NCT07925359 · NAVigate-ULTRA — The Evaluation of User Experience With FARAVIEW™ Technology of… Maladie coronarienne À vérifier Non applicable NOT_YET_RECRUITING The objective of this study is to obtain experience with new and modified… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
SESAME Procedure NCT07806149 · NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective… Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING This is an early study of a catheter-based minimally invasive procedure ca… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Topical cyanoacrylate tissue adhesive NCT07926191 · Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After E… Maladie coronarienne Thérapie génique À vérifier NOT_YET_RECRUITING In July 2026 the electrophysiology laboratory of a Czech tertiary cardiolo… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Truvaga Plus NCT07926945 · U54: nVNS RCT — Effects of nVNS on Stress Reactivity in IBS Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interact… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Capstan Compass Robotic System for Transcatheter Mitral Valve Replace… NCT07917208 · Early Feasibility Study of the Capstan Medical TMVR System Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This early feasibility study is evaluating the safety and performance of t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) NCT07854795 · RELEASE-Norway — Reconsidering Long-Term Apirin in the Elderly in Secondary Prev… Maladie coronarienne À vérifier Phase 4 NOT_YET_RECRUITING Lifelong aspirin has been a cornerstone of secondary prevention after coro… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Extracorporeal Shock Wave Therapy NCT07068399 · CSWT — Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronar… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized single-blind controlled trial aims to compare the effectiv… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Modified ultrafiltration NCT00246779 · A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Su… Maladie coronarienne À vérifier Non applicable COMPLETED Cardiac surgery is a major consumer of blood products worldwide. The natur… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Naproxen NCT07549490 · Human Experimental Models of Pain (HEMP) Maladie coronarienne Immunomodulation · Traitement symptomatique Non applicable NOT_YET_RECRUITING This pilot study will test an innovative way to establish how pain medicin… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Prescription of Aspirin NCT07524335 · ASCAD-P — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Con… Maladie coronarienne À vérifier Phase 3 RECRUITING In patients with subclinical coronary artery disease, the ASCAD-P study ai… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Pulmonary Vein Isolation NCT06402617 · RETRO-AF — Ablation of Focal Activation in Atrial Fibrillation Maladie coronarienne Ralentissement de la progression Non applicable RECRUITING Atrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardi… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Serratus Posterior Superior Intercostal Plane Block With Bupivacaine NCT07588230 · Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardia… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized, double-blind, placebo-controlled study aims to evaluate t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
TAVI NCT07926022 · TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patient… Maladie coronarienne À vérifier À vérifier RECRUITING \# WHAT IS THIS STUDY ABOUT? This study compares two different treatment a… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
This study involved an auxillary CE-marked medical device (implantabl… NCT07545512 · ODISSEY — ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Car… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING Although advances in treatment and patient management have considerably im… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Evolocumab NCT05284747 · EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Maladie coronarienne À vérifier Phase 4 ACTIVE_NOT_RECRUITING The primary objective of this study is to evaluate the effectiveness of ea… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Microaxial flow pump (left ventricular assist device) NCT07762560 · DOUBLE-SHOCK — Routine Microaxial Heart Pump Support and Protocolized Pulmonary… Maladie coronarienne Thérapie génique Non applicable RECRUITING The goal of this clinical trial is to learn which treatment strategies imp… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
No aspirin (Prasugurel monotherapy) NCT05709626 · PREMIUM — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Interven… Maladie coronarienne À vérifier Phase 4 COMPLETED The aim of this study is to evaluate the safety of prasugrel monotherapy w… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Percutaneous Mechanical Circulatory Support NCT06445608 · PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Maladie coronarienne À vérifier Non applicable RECRUITING This purpose of this trial is to demonstrate 30 day safety and effectivene… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
26G Needle NCT07926113 · MASS-NEEDLE — Comparison of 26G and 30G Needles for Masseter Trigger Point Injec… Myopathies Traitement symptomatique Non applicable NOT_YET_RECRUITING This randomized split-face study aims to compare the effects of 26G and 30… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
ABSK021 NCT04192344 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in… Myopathies À vérifier Phase 1 RECRUITING This is an open-label phase 1 study to determine the safety and tolebility… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4871

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Response to "Nanoformulated fingolimod for spinal cord injury: promis… Fingolimod · PMID 42443564 Sclérose en plaques Immunomodulation Publication PubMed Voir la publication source Résumé non disponible dans la base locale. Spinal cord 2026-07-14 16:01:09 Source
Feasibility and sensitivity of a multimodal digital endpoint panel fo… Speech Analysis in ALS Patients · PMID 42405987 Sclérose latérale amyotrophique Ralentissement de la progression Publication PubMed Voir la publication source : The use of digital technology may improve monitoring of amyotrophic lateral sclerosis (ALS) but a multimodal approach… Amyotrophic lateral sclerosis & frontotemporal degener… 2026-07-12 19:43:05 Source
Neural decoding of speech using deep neural ensembles. Real World Testing of a Brain-Computer Interface · PMID 42282632 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Speech brain-computer interfaces (BCIs) can restore rapid communication to people with paralysis, but decoding errors s… bioRxiv : the preprint server for biology 2026-07-12 19:43:05 Source
Reproducible testing for embedded BCIs: a demultiplexing PCB and acqu… Real World Testing of a Brain-Computer Interface · PMID 42256671 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Validating machine learning models for Brain-Computer Interfaces (BCIs) on resource-constrained edge devices is challen… HardwareX 2026-07-12 19:43:05 Source
Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflam… Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS) · PMID 42207242 Sclérose latérale amyotrophique Ralentissement de la progression · Immunomodulation Publication PubMed Voir la publication source Amyotrophic lateral sclerosis (ALS) is a rapidly progressive and fatal neurodegenerative disorder with marked biologica… Molecular neurobiology 2026-07-12 19:43:03 Source
From Environment to Symptoms: Mapping Premorbid Risk Factors onto Cli… Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) · PMID 41830966 Hypertension artérielle · Sclérose latérale amyotrophique Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with multifactorial causes, including ge… Neurology and therapy 2026-07-12 19:43:03 Source
Multimodal analysis of cell-free DNA identifies epigenetic biomarkers… Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS) · PMID 42222887 Sclérose latérale amyotrophique Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source The role of the epigenome in age-related neurodegenerative disorders remains understudied. Here, we analyzed circulatin… The Journal of clinical investigation 2026-07-12 19:43:03 Source
Prospective Validation of the New PLS Diagnostic Criteria From PLS Na… Natural History and Clinical Features of Amyotrophic Lateral Sclerosis (ALS) · PMID 41772409 Sclérose latérale amyotrophique Traitement symptomatique Publication PubMed Voir la publication source Primary lateral sclerosis (PLS) is an ultrarare upper motor neuron syndrome with a prognosis unique from classical ALS.… Muscle & nerve 2026-07-12 19:43:03 Source
Determinants of Repetitive Transcranial Magnetic Stimulation Efficacy… Sham rTMS of the brain · PMID 42428110 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source Repetitive Transcranial Magnetic Stimulation (rTMS) is a promising treatment for tobacco use disorder (TUD). Although a… medRxiv : the preprint server for health sciences 2026-07-12 19:42:56 Source
Ischemic Conditioning Enhances Corticomotor Excitability, Strength, a… Sham rTMS of the brain · PMID 42435025 Accident vasculaire cérébral À vérifier Publication PubMed Voir la publication source This study aimed to evaluate the corticomotor mechanisms and short-term motor effects of ischemic conditioning (IC) app… Neuromodulation : journal of the International Neuromo… 2026-07-12 19:42:56 Source
Psilocybin-assisted therapy in treatment-resistant depression: rapid… Psilocybin · PMID 42433813 Maladie d’Alzheimer · Cancer · Migraine · Maladie de Parkinson · Sclé… Traitement symptomatique Publication PubMed Voir la publication source Treatment-resistant depression (TRD) remains a major clinical challenge and is typically defined as the persistence of… Annals of medicine and surgery (2012) 2026-07-12 19:42:55 Source
Psychedelics produce enduring enhancement of reward responsiveness in… Psilocybin · PMID 42432161 Maladie d’Alzheimer · Cancer · Migraine · Maladie de Parkinson · Sclé… Traitement symptomatique Publication PubMed Voir la publication source Anhedonia, the blunted responsiveness to previously rewarding stimuli, is a core symptom of several psychiatric disorde… Neuropsychopharmacology : official publication of the… 2026-07-12 19:42:55 Source
A multimodal biomarker strategy to enhance diagnostic precision in ne… The Ontario Neurodegenerative Disease Research Initiative · PMID 42157002 Maladie de Parkinson Thérapie génique Publication PubMed Voir la publication source Differential diagnosis of neurodegenerative parkinsonian syndromes is complicated by overlapping clinical features and… Nature medicine 2026-07-12 19:42:52 Source
Application of a clinical scale for predicting Aβ-positivity in a mul… The Ontario Neurodegenerative Disease Research Initiative · PMID 42275797 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source Clinical Amyloid positivity Prediction Score (CAPS) is a clinical tool developed on a small Canadian cohort with clinic… Journal of the neurological sciences 2026-07-12 19:42:52 Source
Multi-omics-guided diagnosis and treatment of toxoplasma retinochoroi… Prednisone · PMID 42436394 Cancer · Insuffisance cardiaque · Lupus · Myasthénie · Myopathies · S… Immunomodulation Publication PubMed Voir la publication source Toxoplasma retinochoroiditis is challenging to diagnose and treat, especially in immunocompromised or co-infected indiv… BMC ophthalmology 2026-07-12 19:42:50 Source
The effects of spinal stabilization exercises in patients with myasth… The Effect of Spinal Stabilization Exercises in Patients With Myasthenia Gravis · PMID 34978954 Myasthénie Traitement symptomatique Publication PubMed Voir la publication source The effects of spinal stabilization exercises (SSE) on fatigue, muscle strength, respiratory functions, functional capa… Disability and rehabilitation 2026-07-12 19:42:49 Source
Clinical characteristics, cerebellar MR spectroscopy and response to… 3, 4-Diaminopyridine · PMID 41065930 Myasthénie Traitement symptomatique Publication PubMed Voir la publication source The clinical and genetic heterogeneity of hereditary ataxias presents a significant diagnostic challenge, particularly… Journal of neurology 2026-07-12 19:42:48 Source
The impact of experimental variables in twitch tension recording on t… 3, 4-Diaminopyridine · PMID 40803653 Myasthénie À vérifier Publication PubMed Voir la publication source Electrophysiological investigations have previously demonstrated that snake venom phospholipase A (PLA) neurotoxins suc… Toxicon : official journal of the International Societ… 2026-07-12 19:42:48 Source
Kidney Survival in Children With Steroid-Resistant Nephrotic Syndrome… Rituximab · PMID 42437162 Maladie rénale chronique Thérapie génique Publication PubMed Voir la publication source Kidney outcomes in children with steroid-resistant nephrotic syndrome (SRNS) following rituximab remain unclear. We con… Kidney international reports 2026-07-12 19:42:44 Source
CD8+ T Cells in Acute Lymphoblastic Leukemia Show a Progenitor-exhaus… Control Group · PMID 42437313 Accident vasculaire cérébral · Myasthénie · Sclérose en plaques Immunomodulation Publication PubMed Voir la publication source Exhausted T cells are phenotypically and functionally heterogeneous, from progenitor- to terminally-exhausted T cells.… Iranian journal of allergy, asthma, and immunology 2026-07-12 19:42:39 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.